Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

NCT03550391 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

206

Enrollment

NETWORK

Sponsor class

Conditions

Brain Metastases

Interventions

DRUG: Memantine
RADIATION: Hippocampal-avoidant (HA-WBRT) Radiotherapy
PROCEDURE: Stereotactic Radiosurgery (SRS)

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]